Found: 182
Select item for more details and to access through your institution.
Priorities in Parkinson's disease research.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Skull Density Ratio as Arm‐Allocation Parameter for a Controlled Focused Ultrasound Trial in Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 7, p. 825, doi. 10.1002/mdc3.14040
- By:
- Publication type:
- Article
UMSARS Versus Laryngoscopy‐Based Assessment of Dysphagia.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 6, p. 974, doi. 10.1002/mdc3.13734
- By:
- Publication type:
- Article
Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 5, p. 479, doi. 10.1002/mdc3.12636
- By:
- Publication type:
- Article
Pharmacological Insights into Levodopa-induced Motor Fluctuations in Patients with Parkinson's Disease.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Current Concepts in the Treatment of Multiple System Atrophy.
- Published in:
- Movement Disorders Clinical Practice, 2015, v. 2, n. 1, p. 6, doi. 10.1002/mdc3.12145
- By:
- Publication type:
- Article
European survey on national harmonization in clinical research.
- Published in:
- Learning Health Systems, 2021, v. 5, n. 2, p. 1, doi. 10.1002/lrh2.10220
- By:
- Publication type:
- Article
Neurofilament light levels predict clinical progression and death in multiple system atrophy.
- Published in:
- Brain: A Journal of Neurology, 2022, v. 145, n. 12, p. 4398, doi. 10.1093/brain/awac253
- By:
- Publication type:
- Article
Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease J. J. Ferreira et al. Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease.
- Published in:
- CNS Neuroscience & Therapeutics, 2010, v. 16, n. 6, p. 337, doi. 10.1111/j.1755-5949.2010.00145.x
- By:
- Publication type:
- Article
Broad white matter impairment in multiple system atrophy.
- Published in:
- Human Brain Mapping, 2021, v. 42, n. 2, p. 357, doi. 10.1002/hbm.25227
- By:
- Publication type:
- Article
Volume and iron content in basal ganglia and thalamus.
- Published in:
- Human Brain Mapping, 2009, v. 30, n. 8, p. 2667, doi. 10.1002/hbm.20698
- By:
- Publication type:
- Article
Orthostatic Hypotension in Patients with Parkinson's Disease.
- Published in:
- Drugs & Aging, 2001, v. 18, n. 7, p. 495, doi. 10.2165/00002512-200118070-00003
- By:
- Publication type:
- Article
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.754016
- By:
- Publication type:
- Article
Distinctive Features of NREM Parasomnia Behaviors in Parkinson’s Disease and Multiple System Atrophy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120973
- By:
- Publication type:
- Article
Influence of Age, Circadian and Homeostatic Processes on Inhibitory Motor Control: A Go/Nogo Task Study.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039410
- By:
- Publication type:
- Article
Recent Advances in Clinical Trials in Multiple System Atrophy.
- Published in:
- Current Neurology & Neuroscience Reports, 2024, v. 24, n. 4, p. 95, doi. 10.1007/s11910-024-01335-0
- By:
- Publication type:
- Article
Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 22, p. 3996, doi. 10.1002/sim.9844
- By:
- Publication type:
- Article
Within-Session and Between-Session Reproducibility of Cerebral Sensorimotor Activation: A Test-Retest Effect Evidenced With Functional Magnetic Resonance Imaging.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2001, v. 21, n. 5, p. 592, doi. 10.1097/00004647-200105000-00014
- By:
- Publication type:
- Article
Cerebral Functional Magnetic Resonance Imaging Activation Modulated by a Single Dose of the Monoamine Neurotransmission Enhancers Fluoxetine and Fenozolone During Hand Sensorimotor Tasks.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 1999, v. 19, n. 12, p. 1365, doi. 10.1097/00004647-199912000-00010
- By:
- Publication type:
- Article
Effect of Side and Rate of Stimulation on Cerebral Blood Flow Changes in Motor Areas During Finger Movements in Humans.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 1993, v. 13, n. 4, p. 639, doi. 10.1038/jcbfm.1993.82
- By:
- Publication type:
- Article
Ergoline and non-ergoline derivatives in the treatment of Parkinson’s disease.
- Published in:
- Journal of Neurology, 2006, v. 253, p. iv36, doi. 10.1007/s00415-006-4009-z
- By:
- Publication type:
- Article
Clinical studies with ropinirole in Parkinson’s disease and RLS.
- Published in:
- Journal of Neurology, 2006, v. 253, p. iv16, doi. 10.1007/s00415-006-4004-4
- By:
- Publication type:
- Article
Levodopa monotherapy can induce “sleep attacks” in Parkinson's disease patients.
- Published in:
- Journal of Neurology, 2001, v. 248, n. 5, p. 426, doi. 10.1007/s004150170188
- By:
- Publication type:
- Article
The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson’s disease.
- Published in:
- Journal of Neurology, 2000, v. 247, p. II51, doi. 10.1007/PL00007761
- By:
- Publication type:
- Article
Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
- Published in:
- Movement Disorders, 1995, v. 10, n. 3, p. 355, doi. 10.1002/mds.870100325
- By:
- Publication type:
- Article
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
- Published in:
- Movement Disorders, 1994, v. 9, n. 4, p. 437, doi. 10.1002/mds.870090410
- By:
- Publication type:
- Article
An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 612, doi. 10.1111/bcp.13145
- By:
- Publication type:
- Article
COMT Inhibitors in the Management of Parkinson's Disease.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 261, doi. 10.1007/s40263-021-00888-9
- By:
- Publication type:
- Article
Evaluation of Prescription Practices of Domperidone in Parkinson's Disease: A Cross Sectional Study Among French Neurologists.
- Published in:
- CNS Drugs, 2020, v. 34, n. 12, p. 1267, doi. 10.1007/s40263-020-00774-w
- By:
- Publication type:
- Article
β-Adrenoceptor Drugs and Parkinson's Disease: A Nationwide Nested Case-Control Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Cross-Sectional Study on Drug Use in Multiple System Atrophy.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 483, doi. 10.1007/s40263-014-0159-1
- By:
- Publication type:
- Article
Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease.
- Published in:
- CNS Drugs, 2010, v. 24, n. 11, p. 941, doi. 10.2165/11537810-000000000-00000
- By:
- Publication type:
- Article
Personality dimensions of patients can change during the course of parkinson's disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245142
- By:
- Publication type:
- Article
Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2009, v. 29, n. 2, p. 235, doi. 10.1038/jcbfm.2008.107
- By:
- Publication type:
- Article
Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere.
- Published in:
- Tremor & Other Hyperkinetic Movements, 2019, p. 1, doi. 10.7916/tohm.v0.663
- By:
- Publication type:
- Article
Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 2, p. 197, doi. 10.1001/jamaneurol.2016.4703
- By:
- Publication type:
- Article
Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease Two Randomized Clinical Trials and Lessons Learned.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 12, p. 1491, doi. 10.1001/jamaneurol.2015.2268
- By:
- Publication type:
- Article
Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 7, p. E1, doi. 10.1001/jamaneurol.2014.753
- By:
- Publication type:
- Article
The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy.
- Published in:
- Brain: A Journal of Neurology, 2011, v. 134, n. 3, p. 856, doi. 10.1093/brain/awq379
- By:
- Publication type:
- Article
Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature.
- Published in:
- Brain: A Journal of Neurology, 2010, v. 133, n. 11, p. 3423, doi. 10.1093/brain/awq212
- By:
- Publication type:
- Article
Tamoxifen and the risk of Parkinsonism: a case/non-case study.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1181, doi. 10.1007/s00228-018-2496-3
- By:
- Publication type:
- Article
A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
- Published in:
- Acta Neuropathologica, 1999, v. 98, n. 1, p. 62, doi. 10.1007/s004010051052
- By:
- Publication type:
- Article
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.994114
- By:
- Publication type:
- Article
Erratum: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 3, p. 412, doi. 10.1002/ana.22192
- By:
- Publication type:
- Article
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 1, p. 18, doi. 10.1002/ana.22060
- By:
- Publication type:
- Article
How much phenotypic variation can be attributed to parkin genotype?
- Published in:
- Annals of Neurology, 2003, v. 54, n. 2, p. 176
- By:
- Publication type:
- Article
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
- Published in:
- Annals of Neurology, 2003, v. 54, n. 1, p. 93
- By:
- Publication type:
- Article
Limitations of current Parkinson's disease therapy.
- Published in:
- Annals of Neurology, 2003, v. 53, n. s3, p. S3
- By:
- Publication type:
- Article